Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Cp (NQ: TECH )

73.78 -0.07 (-0.09%)
Streaming Delayed Price Updated: 11:09 AM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 69,606
Open 73.79
Bid (Size) 73.74 (2)
Ask (Size) 73.82 (2)
Prev. Close 73.85
Today's Range 73.38 - 74.18
52wk Range 69.81 - 455.22
Shares Outstanding 157,275,200
Dividend Yield 1.73%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Thursday Is Your Last Chance To Buy Bio-Techne Before The Dividend Payout
 
Via Benzinga
Analyst Expectations for Bio-Techne's Future
 
Via Benzinga

Performance

YTD
-10.60%
-10.60%
1 Month
+0.16%
+0.16%
3 Month
-8.95%
-8.95%
6 Month
-75.41%
-75.41%
1 Year
-83.16%
-83.16%

More News

Read More
Earnings Outlook For Bio-Techne
Via Benzinga
5 Cheapest Health Care Stocks You Should Think About
Via Benzinga
5 Health Care Stocks That Are Diving - And May Rally
Via Benzinga
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
Via Benzinga
Bio-Techne: Q1 Earnings Insights
Via Benzinga
Recap: Bio-Techne Q4 Earnings
Via Benzinga
Recap: Bio-Techne Q3 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Our 7 Top Biotech Stock Picks for 2023
Via InvestorPlace
Earnings Scheduled For November 1, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Via Benzinga
Tackling Recurring Health Conditions Offers Hope to Patients
Via FinancialNewsMedia
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
7 Defensive Growth Stocks to Buy for a Shaky Market
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
Via Benzinga
7 Superior Stocks That Smart Investors Will Buy on the Dip
Via InvestorPlace
10 Biggest Price Target Changes For Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.